Escalon Medical Corp.
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals for ophthalmology. Products include A-Scan, B-Scan, UBM, Pachymeter, and Ispan Intraocular Gases. The company also provides AXIS Image management system and disposable surgical packs for vitreoretinal surgery. Additionally, it manufactures and distributes a patented universal gas kit. Escalon sells its products to medical institutions through sales reps, distributors, and internal employees. The company was incorporated in 1987 and is headquartered in Pennsylvania.
Overview
Strengths
- With an appreciation Potential of 149.29%, based on our fundamental analysis, it suggests the stock may be undervalued.
- Current Price to Earnings Ratio (12.65) is lower than the sector mean (123.56).
- Price to book ratio (0.70) is lower than the sector mean (13.90).
- Earnings are projected to grow at a solid rate (19.1% per year).
- The company has high returns. ROIC (17.43%) is higher than the sector mean (2.97%).
- EV/EBITDA (6.37) is lower than the sector mean (222.25).
- EV/EBIT (8.25) is lower than the sector mean.
- Price to free cash flow (3.54) is lower than the sector mean.
Weaknesses
- The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
- EBITDA Margin (1.38%) appears relatively low.
Key Financial Data